New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
Publication
, Journal Article
Mairs, RJ; Zalutsky, MR
Published in: Br J Cancer
July 1995
Duke Scholars
Published In
Br J Cancer
DOI
ISSN
0007-0920
Publication Date
July 1995
Volume
72
Issue
1
Start / End Page
250
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neuroblastoma
- Iodobenzenes
- Iodine Radioisotopes
- Humans
- Combined Modality Therapy
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 3-Iodobenzylguanidine
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Mairs, R. J., & Zalutsky, M. R. (1995). New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment. Br J Cancer, 72(1), 250. https://doi.org/10.1038/bjc.1995.312
Mairs, R. J., and M. R. Zalutsky. “New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.” Br J Cancer 72, no. 1 (July 1995): 250. https://doi.org/10.1038/bjc.1995.312.
Mairs RJ, Zalutsky MR. New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment. Br J Cancer. 1995 Jul;72(1):250.
Mairs, R. J., and M. R. Zalutsky. “New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.” Br J Cancer, vol. 72, no. 1, July 1995, p. 250. Pubmed, doi:10.1038/bjc.1995.312.
Mairs RJ, Zalutsky MR. New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment. Br J Cancer. 1995 Jul;72(1):250.
Published In
Br J Cancer
DOI
ISSN
0007-0920
Publication Date
July 1995
Volume
72
Issue
1
Start / End Page
250
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neuroblastoma
- Iodobenzenes
- Iodine Radioisotopes
- Humans
- Combined Modality Therapy
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 3-Iodobenzylguanidine
- 1117 Public Health and Health Services